MAPK3 and neoplasm: Exhibits anti-metastatic ability, both in vitro and in vivo. Induces regulatory effects on Actin dynamics in an FAK/ERK1/2-dependent manner, which might be further attributed to its binding to FN and, consequently, FN-induced tumor adhesion, and migration.